Thus, inhibition of CXCL12 binding to its receptors by NOX-A12 spiegelmers has the potential to interfere with the CXCL12 anchor and prompt leukemia stems cells to re-enter the cell cycle and become available for chemotherapeutic attack. The gene discussed is CXCL12; the disease is leukemia.